PARTICIPANT'S NAME
ORGANIZATION
TITLE/AREA OF SPECIALTY
DR. MOHAMMED AKHTER
DR. CARLA ALEXANDER
DR. JOSE BORDON
Providence Hospital JOSE BORDON, MD, PH.D, AAHIV, Chief, Section of Infectious Diseases. Dr. Bordon is the Chief of the Section of Infectious Diseases, Providence Health System at Washington, D.C. Dr. Bordon has worked for the last 15 years in establishing service models for the optimal care of HIV and HCV-infected individuals. He has written more than 40 peer reviewed original manuscripts and he is the reviewer of more than 12 scientific journals. Dr. Bordon is devoted of the holistic care service for the better care of individuals with multiple unmet needs including HIV infection, viral hepatitis, substance abuse, mental health conditions, etc.
DR. ROBERT CALDWELL
Engility Corporation Chief Scientist for Medical Affairs Pathology, Virology, Multi-Drug Resistance
DR. HOWELL CHARLES
Howard University CHARLES HOWELL, MD, AGAF, FAASLD Professor and Chair, Department of Medicine, College of Medicine / Howard University
DANE R. CHRISTIANSEN
Hepatitis Foundation International DANE CHRISTIANSEN, MBA has over a decade of experience advancing medical research and access to care issues for patient-driven communities. He is Vice President of the Health and Medicine Counsel of Washington and previously served as Grassroots Coordinator for the Dystonia Medical Research Foundation and Development Coordinator for the International Foundation for Functional Gastrointestinal Disorders. Recently, he completed his MBA in multi-sector healthcare management from Saint George’s University.
DR. NNEMDI ELIAS, MD
United Medical Center MD, Director of Care Center and Population Health Social determinants of health impact on health equity; health literacy; underserved population.
ROXANNE ELLIS-DENBY
National Association of Black Social Workers, Inc LCSW LPN/ Vice President Mental Health/ Trauma, Crisis Management, and Substance Abuse
DR. DAWN FISHBEIN
Scientific Director, Viral Hepatitis Research Director, MedStar Research Clinical Research Unit, GHUCCTS
GLEN GILES
Anomaly 42
MARK HAUGHTON
AbbVie Health Systems Executive
DR. RICHARD LEVINSON
DC Department of Health Senior Deputy Director for Medical Affairs Gastroenterology, Preventative medicine
DR. PARTHA SARATH MUKHERJEE
Live Foundation, West Bengal PARTHA SARATHI MUKHERJEE, M.Sc. Ph. D (Physiology) from Calcutta University, trained in Public Health Monitoring & Evaluation Project Director & Chief Functionary, Liver Foundation, West Bengal, engaged in public health research Total 22 paper and abstract publications, Carried out 19 projects and attended 26 international conferences. Lectures Delivered at Overseas: 14 (USA, Brazil, Scotland, Taiwan, Beijing, Hong Kong, Bangkok etc). Hepatitis education and research, Prevention of liver disease as public health priority, hepatitis patients' (B & C) advocacy
DR. CLAIRE NELSON
The Futures Forum Chief Ideation Leader Strategic Foresight, technology Assessment
DR. GREGORY PAPPAS
Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration GREGORY PAPPAS, MD, Ph.D. is the Associate Director for Medical Device Surveillance at Center for Devices and Radiological Health (CDRH) at the Food and Drug Administration. He previously served as the Senior Deputy Director of HAHSTA (HIV/AIDS, Hepatitis, STD, and TB Administration) for the District of Columbia, Department of Health. He has worked professionally in over 30 countries. His consultancies include work with WHO, USAID, and CDC. With InterAction,–the largest coalition of U.S.-based international nongovernmental organizations (NGOs) focused on the world’s poor and most vulnerable people — he worked on pandemic prepared with 40 African and Asian nations.
DR. LISA PAWLOSKI
George Mason Univeristy CHHS LISA PAWLOSKI, Ph.D is a Professor in Nutrition and Food Studies at George Mason University in Fairfax, Virginia. She received her PhD in Bioanthropology from Indiana University in 1999. Most recently she served as Dean of Academic Affairs at the GMU Korea campus in Incheon, Korea and will return as Chair of the Department of Nutrition and Food Studies in Fairfax, Virginia starting Fall 2016. Her research focuses on the nutrition transition, obesity, and biocultural factors which influence diet and nutritional status.
DR. RAMA RAGHUNANDAN
Hepatitis Foundation International Immunology
DR. SWAMIDOSS
SHARON F. TERRY
Genetic Alliance SHARON F. TERRY is President and CEO of Genetic Alliance, which engages individuals, families, and communities to transform health. Genetic Alliance provides programs and products for people to take charge of their health and further research. She serves in a leadership role on many of the major international and national organizations.
JACK WALLACE
Australian Research Centre in Sex, Health and Society. La Trobe University Research Fellow Social impact; policy responses; non-clinical impact of viral hepatitis; viral hepatitis responses in the Asia Pacific region
CLARA WILKERSON
• Dr. Zarfishan Zahid, MD
Providence Hospital Hepatitis B and C: education and prevention; treatment and management; targeting the hard to reach/hard to treat patient population; clinical research and advancement Hepatitis C eradication